New System Helps Check Tablet Quality During Manufacturing
A team of researchers in Japan has developed a new way to check the quality of medicine tablets as they […]
Pharmaceutical News
New FDA-Approved Autoinjector for Alzheimer’s Treatment Offers Convenient Option
Eisai and Biogen have received FDA approval for LEQEMBI IQLIK (lecanemab-irmb), a new autoinjector for maintaining treatment in early Alzheimer’s
Biotech Investor Otello Stampacchia on Industry Challenges and Future Outlook
Otello Stampacchia, a seasoned biotech investor, has seen the industry face many tough times over the past 20 years. He
New Startup Braveheart Bio Licenses Chinese Heart Drug for Global Development
A new pharmaceutical startup called Braveheart Bio has just acquired the rights to a promising heart medication originally developed in
FDA Reconsiders Rare Disease Drug, Setting Precedent for Future Treatments
A debate between Stealth BioTherapeutics and the FDA over a drug for Barth syndrome—a rare, often fatal childhood disease—could set
Pharmaceutical News
Gilead Builds AI-Powered US Manufacturing Hub to Boost Drug Innovation
Gilead Sciences has started construction on a new high-tech manufacturing center in the Bay Area, a key part of its
EMA Warns of Dangerous Fake Weight Loss Drugs Flooding the Market
The European Medicines Agency (EMA) has issued a serious warning about a sharp rise in illegal weight loss drugs being
Upcoming Advisory Meeting to Discuss COVID and Other Vaccines Amid Policy Changes
A recent government notice confirmed the dates for an important meeting where experts will discuss and possibly vote on recommendations
Pharmaceutical News
Teva Gets FDA Approval for Generic Obesity Drug, While Eli Lilly’s New Weight Loss Pill Shows Promise
Teva Pharmaceuticals has received US approval for its generic version of liraglutide, a drug used to help with weight loss.
Key Updates from Major Pharmaceutical Companies: Amylyx, Sanofi, Novartis, Roche, and Eisai
Here’s a quick rundown of recent news from major pharmaceutical companies that you might have missed. Amylyx Pharmaceuticals announced that